GEN and GNMSF Related Headlines

Go Back

GEN and GNMSF Related Press Releases

Go Back

Nov 24, 2014 08:53AM Genmab Announces Phase II Study of Daratumumab in Smoldering Multiple Myeloma
Nov 10, 2014 03:17AM Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma
Nov 6, 2014 09:40AM Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology Annual Meeting (ASH)
Nov 6, 2014 09:10AM Genmab Announces Additional Data from Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL
Nov 5, 2014 11:23AM Genmab Announces Financial Results for the First Nine Months of 2014
Nov 3, 2014 01:24AM Genmab Announces Conditional Transfer of Ofatumumab Agreement
Oct 23, 2014 12:51PM Genmab Reaches USD 10 Million Milestone in Daratumumab Collaboration with Janssen
Oct 22, 2014 07:05AM Third Quarter 2014 Net Sales Figures for Arzerra(r)
Sep 10, 2014 08:15AM Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration

GEN and GNMSF Related SEC Filings

Go Back